ENTRY       D09595            Mixture   Drug
NAME        Budesonide and formoterol fumarate dihydrate;
            Symbicort (TN);
            Budeforu (TN)
PRODUCT     SYMBICORT (AstraZeneca Pharmaceuticals LP)
  GENERIC   BREYNA (Mylan Pharmaceuticals)
            BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE (A-S Medication Solutions)
            BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE (A-S Medication Solutions)
            BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE (AstraZeneca Pharmaceuticals LP)
            BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE (RPK Pharmaceuticals)
COMPONENT   Budesonide [DR:D00246], Formoterol fumarate [DR:D05277]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
REMARK      Therapeutic category: 2290
            ATC code: R03AK07
            Product: D09595<JP/US>
EFFICACY    Antiasthmatic
  DISEASE   Asthma [DS:H00079]
            Chronic obstructive pulmonary disease [DS:H01714]
COMMENT     Budesonide is primarily metabolized by CYP3A4.
            Formoterol is primarily metabolized by UDP-glucuronosyltransferase (UGT).
METABOLISM  Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03A ADRENERGICS, INHALANTS
                R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
                 R03AK07 Formoterol and budesonide
                  D09595  Budesonide and formoterol fumarate dihydrate &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Bronchodilator Combinations
               Budesonide/ Formoterol Fumarate Dihydrate
                D09595  Budesonide and formoterol fumarate dihydrate
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               229  Miscellaneous
                2290  Miscellaneous
                 D09595  Budesonide and formoterol fumarate dihydrate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D09595  Budesonide and formoterol fumarate dihydrate
              DG02924  UGT substrate
               D09595  Budesonide and formoterol fumarate dihydrate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09595
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09595
DBLINKS     PubChem: 124490335
///
